Survival of beta-lactamase-producing and -nonproducing bacteria in intravenous solutions

DICP : the Annals of Pharmacotherapy
P G Hugbo, U E Akpan

Abstract

The survival of beta-lactamase-producing (beta-lac+) and non-beta-lactamase-producing (beta-lac-) Bacillus and Staphylococcus spp. has been investigated in dextrose 5% injection, NaCl 0.9%, and dextrose 5% in NaCl 0.9% solutions. Tests were performed under static and turbulent conditions of incubation, with and without antibiotics added to the fluids, and with or without 1% citrated blood. All solutions were inoculated with about 1000 organisms/mL, and sampled for viable bacteria at specific time intervals. Under static conditions, there was no significant decrease in viability (p greater than 0.01) of the bacilli, except for the staphylococci (p less than 0.01). However, when cultures were agitated, all species showed significant decline in viability (p less than 0.01). When antibiotics were present, S. aureus (beta-lac+) declined gradually throughout 24 hours (p greater than 0.01). B. cereus (beta-lac+) concentrations were static in all solutions. All organisms multiplied rapidly in solutions containing blood. The results suggest that the growth characteristics of both beta-lac+ and beta-lac- bacteria in intravenous fluids are essentially similar, except in solutions containing beta-lactamase-sensitive antibiotics in which be...Continue Reading

References

Apr 1, 1979·The Journal of Applied Bacteriology·C J Holmes, M C Allwood
Sep 1, 1975·The Journal of Antimicrobial Chemotherapy·A G Ayliffe
Sep 1, 1986·JPEN. Journal of Parenteral and Enteral Nutrition·M GilbertM F Elmore
Jul 1, 1987·Drug Intelligence & Clinical Pharmacy·C E RoweJ T Martinoff
Dec 31, 1971·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·G N Rolinson
Nov 15, 1971·JAMA : the Journal of the American Medical Association·H C Ansel, M P Gigandet
Jul 1, 1983·Drug Intelligence & Clinical Pharmacy·S A Hunt, M J Rybak
Nov 1, 1938·The Journal of Hygiene·A A MilesJ O Irwin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacillus Cereus Infection

Bacillus Cereus is a gram-positive bacteria that is the cause of some foodborne illnesses and leads to diarrhea and vomiting. Discover the latest research on Bacillus Cereus Infection here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.